Embecta Corp
Open
SectorHealthcare
5.28 1.93
Overview
Share price change
24h
Min
5.08
Max
5.21
Income | 25M 21M |
|---|---|
Sales | 50M 272M |
P/E Sector Avg | 3.565 56.432 |
EPS | 0.56 |
Dividend yield | 9.31 |
Profit margin | 7.766 |
Employees | 1,850 |
EBITDA | 17M 62M |
Dividend yield Sector Avg | 9.31% 2.27% |
|---|---|
Next Earnings | 24 lis 2026 |
Next Dividend date | 17 gru 2026 |
Next Ex Dividend date | 4 gru 2026 |
Market Cap | 76M 297M |
|---|---|
Previous open | 3.35 |
Previous close | 5.28 |
News Sentiment
By Acuity
29%
71%
46 / 339 Ranking in Healthcare
Embecta Corp Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Embecta Corp Forecast
Sentiment
By Acuity
46 / 339 Ranking in Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Embecta Corp
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.